News
People paying privately for weight-loss drug Mounjaro in the UK face a rise in the cost of the treatment after manufacturer ...
Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out ...
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results